Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Neuvonen

Showing results (151-160 of 334) with videos related to

Pageof 34
Sort By:
British Journal of Anaesthesia|January 30, 1999
The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanylV J Palkama, P J Neuvonen, K T Olkkola
Clinical Pharmacology and Therapeutics|January 1, 1996
Rifampin drastically reduces plasma concentrations and effects of oral midazolamJ T Backman, K T Olkkola, P J Neuvonen
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendanS Antila, T Honkanen, L Lehtonen, et al.
Experientia|December 1, 1973
Inhibition of the apomorphine gnawing compulsion by amantadineR Hackman, P Pentikainen, P J Neuvonen, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|June 23, 2001
Ketamine for procedural pain relief in newborn infantsE Saarenmaa, P J Neuvonen, P Huttunen, et al.
Arzneimittel-Forschung|March 1, 1975
Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA)H Vapaatalo, D Onken, P J Neuvonen, et al.
Pharmacology & Toxicology|March 6, 1999
Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspironeK T Kivistö, T S Lamberg, P J Neuvonen
British Journal of Clinical Pharmacology|October 1, 1991
The bioavailability of sustained release nicotinic acid formulationsP J Neuvonen, L Roivas, K Laine, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
Sotalol prolongation of the QTc interval in hypertensive patientsP J Neuvonen, E Elonen, A Tanskanen, et al.
European Journal of Clinical Pharmacology|April 1, 1980
Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liverP J Pentikäinen, P J Neuvonen, K G Jostell
Pageof 34

Showing results (151-160 of 334) with videos related to

Sort By:
Pageof 34
British Journal of Anaesthesia|January 30, 1999
The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanylV J Palkama, P J Neuvonen, K T Olkkola
Clinical Pharmacology and Therapeutics|January 1, 1996
Rifampin drastically reduces plasma concentrations and effects of oral midazolamJ T Backman, K T Olkkola, P J Neuvonen
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendanS Antila, T Honkanen, L Lehtonen, et al.
Experientia|December 1, 1973
Inhibition of the apomorphine gnawing compulsion by amantadineR Hackman, P Pentikainen, P J Neuvonen, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|June 23, 2001
Ketamine for procedural pain relief in newborn infantsE Saarenmaa, P J Neuvonen, P Huttunen, et al.
Arzneimittel-Forschung|March 1, 1975
Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA)H Vapaatalo, D Onken, P J Neuvonen, et al.
Pharmacology & Toxicology|March 6, 1999
Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspironeK T Kivistö, T S Lamberg, P J Neuvonen
British Journal of Clinical Pharmacology|October 1, 1991
The bioavailability of sustained release nicotinic acid formulationsP J Neuvonen, L Roivas, K Laine, et al.
Clinical Pharmacology and Therapeutics|July 1, 1982
Sotalol prolongation of the QTc interval in hypertensive patientsP J Neuvonen, E Elonen, A Tanskanen, et al.
European Journal of Clinical Pharmacology|April 1, 1980
Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liverP J Pentikäinen, P J Neuvonen, K G Jostell
Pageof 34